These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9678728)

  • 1. Effusion cytology of renal cell carcinoma.
    Renshaw AA; Comiter CV; Nappi D; Granter SR
    Cancer; 1998 Jun; 84(3):148-52. PubMed ID: 9678728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphology of ovarian clear cell carcinomas in peritoneal effusions.
    Damiani D; Suciu V; Genestie C; Vielh P
    Cytopathology; 2016 Dec; 27(6):427-432. PubMed ID: 26932246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma.
    Ascoli V; Bosco D; Carnovale Scalzo C
    Pathologica; 2011 Dec; 103(6):318-24. PubMed ID: 22558888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings.
    Teresa P; Grazia ZM; Doriana M; Irene P; Michele S
    Diagn Cytopathol; 2012 Jan; 40(1):56-61. PubMed ID: 22180239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology of metastatic renal medullary carcinoma in pleural effusion: a study of two cases.
    Ellis CL; Burroughs F; Michael CW; Li QK
    Diagn Cytopathol; 2009 Nov; 37(11):843-8. PubMed ID: 19526572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
    Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
    Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
    Pillai V; Cibas ES; Dorfman DM
    Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature.
    Davidson B
    Anal Cell Pathol; 2001; 23(3-4):107-28. PubMed ID: 12082292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
    Gupta S; Sodhani P; Jain S
    J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphologic features of metastatic urothelial carcinoma in serous effusions.
    Huang CC; Attele A; Michael CW
    Diagn Cytopathol; 2013 Jul; 41(7):569-74. PubMed ID: 22833290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.
    Lew M; Pang JC; Roh MH; Jing X
    Acta Cytol; 2015; 59(5):412-7. PubMed ID: 26587773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant pleural effusion resulting from metastasis of thyroid primaries: a cytomorphological analysis.
    Olson MT; Nuransoy A; Ali SZ
    Acta Cytol; 2013; 57(2):177-83. PubMed ID: 23406984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.
    He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS
    World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.
    Delahunt B; Eble JN
    Mod Pathol; 1997 Jun; 10(6):537-44. PubMed ID: 9195569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
    Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
    Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.